Nom du produit:ethyl 5,6-dichloropyrimidine-4-carboxylate

IUPAC Name:ethyl 5,6-dichloropyrimidine-4-carboxylate

CAS:1097250-57-1
Formule moléculaire:C7H6Cl2N2O2
Pureté:95%
Numéro de catalogue:CM166965
Poids moléculaire:221.04

Unité d'emballage Stock disponible Prix($) Quantité
CM166965-100mg in stock Žħǟ
CM166965-250mg in stock ǎǸǎ
CM166965-1g in stock ƴijij

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1097250-57-1
Formule moléculaire:C7H6Cl2N2O2
Point de fusion:-
Code SMILES:O=C(C1=NC=NC(Cl)=C1Cl)OCC
Densité:
Numéro de catalogue:CM166965
Poids moléculaire:221.04
Point d'ébullition:321.5±37.0°C at 760 mmHg
N° Mdl:MFCD22124090
Stockage:Store at 2-8°C.

Category Infos

Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

Column Infos

Tovorafenib
Tovorafenib is a highly selective, brain-penetrating pan-RAF kinase inhibitor designed to target key enzymes in the MAPK signaling pathway. Tovorafenib has been granted Breakthrough Therapy Designation by the U.S. FDA for the treatment of pediatric patients with low-grade gliomas harboring RAF mutations. The hope is to bring this therapy soon to children in need of new treatment options.

Related Products